What's The BUZZ?

Market News, Products, Services, and Trends

Endo

Endo Launches Tiopronin Delayed-Release Tablets, Generic Version of THIOLA EC®

read more

MALVERN, Pa., July 15, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics’ THIOLA EC®.

“We’re proud to provide high-quality, affordable choices to healthcare providers and their appropriate patients,” said Scott Sims, Senior Vice President and General Manager, Endo Injectable Solutions & Generics. “The launch of tiopronin delayed-release tablets strengthens our generic product portfolio and underscores our reputation as a reliable supplier.”

The medication is used in combination with high fluid intake, alkali (low acid), and dietary changes to help prevent the formation of one type (cystine) of kidney stones in certain adult and pediatric patients.

As a demonstration of its commitment to patients, Endo is offering copay assistance for those who meet eligibility requirements. To learn more about Endo’s Patient Assistance Program, patients can call (833) 727-4357.

THIOLA EC® is a registered trademark of Mission Pharmacal Company. Read More >

TODAY'S POSTS
SUBSCRIBE
Endo

Endo News & Announcements

Through our long-standing work in endocrinology, orthopedics, and urology, as well as in hospital systems and with retail generic medications, we have developed an unmatched understanding of those we serve. We will never stop learning how to make a real difference in people’s lives. We partner with hospitals and healthcare systems to reduce complexity through life-enhancing solutions, innovating together to add value where it matters—from manufacturing to treatment—so that healthcare providers can focus on patient care. We deliver high-quality, affordable generic medicines to patients in need through excellence in development, manufacturing, and commercialization. Drawing from over four decades of experience in the U.S. generic pharmaceutical market, we have built a well-established reputation for compliance and exceptional customer service.

PROFILE
WEBSITE
10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

PROFILE
LINKEDIN
WEBSITE

This post is related to:

TODAY'S POSTS

Connect with RXinsider

Stay informed on pharmacy supply chain news, market trends, and product releases by subscribing to RXinsider’s emails, newsletters, and publications. If building awareness with pharmacy management is part of your marketing strategy, consider advertising with RXinsider.

Subscribe
Advertise

RXinsider
1300 Division Road, Suite 103
West Warwick, RI 02893

The BUZZ / News

Publications

Marketplace

Multimedia Content

Market Intelligence

Career Center

Subscribe

Company

Subscribe
© 2025 RXinsider | All Rights Reserved.

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from Endo Launches Tiopronin Delayed-Release Tablets, Generic Version of THIOLA EC®

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe